Impaired gene-expression and epigenetic regulation of retinoic acid receptor responder 1 in preeclampsia and choriocarcinoma [Abstract]
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Placenta, 45, S. 64-
- Classification
-
Medizin, Gesundheit
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2016
- Event
-
Veröffentlichung
- (who)
-
Elsevier BV
- (when)
-
2016
- Creator
-
Huebner, Hanna
Fahlbusch, Fabian B.
Strissel, Pamela L.
Strick, Reiner
Wachter, David
Beckmann, Matthias W.
Ruebner, Matthias
- DOI
-
10.1016/j.placenta.2016.06.014
- URN
-
urn:nbn:de:bvb:384-opus4-1061835
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Huebner, Hanna
- Fahlbusch, Fabian B.
- Strissel, Pamela L.
- Strick, Reiner
- Wachter, David
- Beckmann, Matthias W.
- Ruebner, Matthias
- Universität Augsburg
- Elsevier BV
Time of origin
- 2016
Other Objects (12)
Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma
Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma
Artificial First Responder
Hypoxische pulmonale Vasokonstriktion bei experimenteller Hypoxie : Responder und Non-Responder
Choriocarcinoma syndrome after resection of primary pulmonary choriocarcinoma: report of a case
¡Cómo iba a responder!
Metastasis of Testicular Choriocarcinoma in the Stomach, Complicated by the Development of Choriocarcinoma Syndrome
Disseminated gestational choriocarcinoma presenting with hepatic and uveal metastases, hook effect, and choriocarcinoma syndrome
A olvido hay que responder
Responder identification in clinical trials
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles
Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma
Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma
Artificial First Responder
Hypoxische pulmonale Vasokonstriktion bei experimenteller Hypoxie : Responder und Non-Responder
Choriocarcinoma syndrome after resection of primary pulmonary choriocarcinoma: report of a case
¡Cómo iba a responder!
Metastasis of Testicular Choriocarcinoma in the Stomach, Complicated by the Development of Choriocarcinoma Syndrome
Disseminated gestational choriocarcinoma presenting with hepatic and uveal metastases, hook effect, and choriocarcinoma syndrome
A olvido hay que responder
Responder identification in clinical trials
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles
Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma
Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma
Artificial First Responder
Hypoxische pulmonale Vasokonstriktion bei experimenteller Hypoxie : Responder und Non-Responder
Choriocarcinoma syndrome after resection of primary pulmonary choriocarcinoma: report of a case
¡Cómo iba a responder!
Metastasis of Testicular Choriocarcinoma in the Stomach, Complicated by the Development of Choriocarcinoma Syndrome
Disseminated gestational choriocarcinoma presenting with hepatic and uveal metastases, hook effect, and choriocarcinoma syndrome
A olvido hay que responder
Responder identification in clinical trials
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy